Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GX-H9 in Pediatric Growth Hormone Deficiency
NCT03309891Phase 2Completed
- Sponsor
- Genexine
- Start
- Jan 2016
- Primary completion
- Oct 2017
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of eftansomatropin alfa in growth hormone deficiency (GHD), sponsored by Genexine. Started Jan 2016; status: completed.
02
Drugs
eftansomatropin alfa
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT03309891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03309891.